SIF

PROGRAMMA ED ABSTRACT

Symposia Abstracts

Innovation and technology for a competitive and sustainable health care system 23 ottobre ore 15.00-16.00 Sala 500
Rifaximin, an Ever Green Antibiotic: New Insights and New Therapeutic Applications 23 ottobre ore 15.00-16.30 Sala Dublino
Clinical Research in Italy: how to compete? 23 ottobre ore 15.00-17.00 Auditorium
Nanomedicines for cancer therapy 23 ottobre ore 15.00-17.00 Sala Madrid
SIF-SINPF-SIP-SITOX Neurobiological and Clinical Continuum Between Psychopathology on Abuse of Substances: the Utility and Criticism of Pharmacotherapy 24 ottobre ore 11.00-13.00 Sala 500
Pharmacological innovation in onco-hematology 24 ottobre ore 11.00-13.00 Sala Madrid
Pharmacological management of patients at high cardiovascular risk 24 ottobre ore 11.00-13.00 Sala Londra
Aspetti farmacologici, clinici e regolatori delle Tossine Botuliniche 24 ottobre ore 11.00-13.00 Sala Copenhagen
Innovation beyond biotechnological drugs: the role of small molecules as target therapy 24 ottobre ore 11.30-13.00 Auditorium
Adherence and economic sustainability in cardiovascular treatment 24 ottobre ore 12.00-13.00 Sala Dublino
Alzheimer disease: today's update 24 ottobre ore 15.00-16.00 Sala Londra
SIF-SISA: The challenge of innovation in cardiovascular medicine between the unmet needs and the sustainability of the healthcare system 24 ottobre ore 15.00-17.00 Sala 500
Taking ragional decisions in a world of uncertainty: how to use pharmaco-economics for reimbursement of new drugs 24 ottobre ore 15.00-17.00 Sala Madrid
Stato attuale e prospettive della farmacologia clinica dell'età pediatrica 24 ottobre ore 15.00-17.00 Sala Copenhagen
The innovation of targeted therapy in the treatment of Hodgkin Lymphoma and sALCL (Systemic Anaplastic Large Cell Lymphoma) 24 ottobre ore 16.00-17.00 Auditorium
Quality of equivalent (generic) drugs 24 ottobre ore 16.00-17.00 Sala Dublino
Emerging role of the endocannabinoid signaling in neuropsychiatric disorders 24 ottobre ore 17.00-19.00 Auditorium
Clinical pharmacology and public health 24 ottobre ore 17.00-19.00 Sala Madrid
Alzheimer disease: identification of novel targets and therapeutic tools 24 ottobre ore 17.00-19.00 Sala Londra
The need of Mitochondrial Pharmacology 24 ottobre ore 17.00-19.00 Sala Copenhagen
Enzymes regulating the intra- and extra-cellular activities of purines and their antineoplastic analogues: new pathophysiological and pharmacological perspectives 24 ottobre ore 17.00-19.00 Sala Dublino
Cardiac Stem Cells Ten Years Later: future developments 24 ottobre ore 17.00-19.00 Sala Lisbona
Inflammation and vulnerability to neuropsychiatric disorders: molecular mechanisms and clinical outcomes 24 ottobre ore 8.30-10.30 Sala 500
Neurodegenerative diseases and brain injury: from cellular and molecular mechanisms to new neuroprotective strategies 24 ottobre ore 8.30-10.30 Sala Madrid
Before, during and after drugs: stay healthy while saving 25 ottobre ore 11.00-12.00 Sala Copenhagen
Rare diseases: from gene to therapy: few bricks in the wall 25 ottobre ore 11.00-13.00 Sala Lisbona
Innovation and sustainability in a time of financial crisis 25 ottobre ore 11.30-13.00 Sala 500
Adherence to therapy and sustainability: a new paradigm for the future 25 ottobre ore 15.00-16.00 Sala 500
Update in pharmacological therapy of T2 Diabetes Mellitus 25 ottobre ore 15.00-17.00 Sala Madrid
Gender medicine. Increasing appropriateness and sustainability through a sex-oriented approach 25 ottobre ore 16.00-17.00 Auditorium
New paths for the treatment of alcohol addiction 25 ottobre ore 16.00-17.00 Sala 500
New research on neurodegeneration: time to translate it to clinic? 25 ottobre ore 8.30-10.30 Sala 500
Stress as a risk factor for neuropsychiatric disorders. Cognitive and metabolic aspects. 25 ottobre ore 8.30-10.30 Sala Madrid
Nuovi bersagli farmacologici nella malattia di Parkinson 25 ottobre ore 8.30-10.30 Sala Copenhagen
Insights in purinergic signalling in normal and pathological conditions of different cells and tissues 25 ottobre ore 8.30-10.30 Sala Dublino
A new drug, today on the market… do we really know it? How to lose the gap of drug characterization in early clinical development 26 ottobre ore 11.00-12.00 Sala 500
Phenotyping of chronic obstructive pulmonary disease and personalized pharmacological therapy 26 ottobre ore 11.00-13.00 Sala Madrid
SIF-SIPHAR Symposium: Herbal products in research and practice: between lights and shadows 26 ottobre ore 11.00-13.00 Sala Copenhagen
SIF/EBRA Joint Symposium: The use of animals for scientific purposes: which implications for Italian research? 26 ottobre ore 11.00-13.00 Sala Lisbona
SIF-AIOM: La farmacogenetica come strumento di personalizzazione della terapia antitumorale 26 ottobre ore 12.00-13.00 Sala 500
Brain development and synaptic organization: regulation by intellectual disability genes and immune molecules 26 ottobre ore 8.30-10.30 Sala Madrid